Oxford Cannabinoid Technologies Holdings Plc (LON:OCTP – Get Free Report) fell 4.2% during mid-day trading on Wednesday . The stock traded as low as GBX 0.12 ($0.00) and last traded at GBX 0.12 ($0.00). 11,402,242 shares changed hands during mid-day trading, an increase of 22% from the average session volume of 9,326,041 shares. The stock had previously closed at GBX 0.12 ($0.00).
Oxford Cannabinoid Technologies Price Performance
The firm’s 50-day moving average price is GBX 0.12 and its 200 day moving average price is GBX 0.23. The firm has a market capitalization of £1.25 million, a price-to-earnings ratio of -53.10 and a beta of 0.82.
About Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.
Featured Stories
- Five stocks we like better than Oxford Cannabinoid Technologies
- What is an Earnings Surprise?
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- 5 Top Rated Dividend Stocks to Consider
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- How to Use Stock Screeners to Find Stocks
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.